Study of the efficacy of the trypsinized autologous non-cultured melanocyte cells graft in the treatment of refractory and stable vitiligo

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130812014333N146

Enrollment

104

Registered

2020-04-06

Start date

2020-03-10

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo. Vitiligo

Interventions

In the intervention group, autologous transplantation of non-cultured melanocytes is performed. Topical anesthesia will be performed with lidocaine 2% and the healthy epidermis was shaved using curett

Eligibility

Sex/Gender

All

Age

15 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with stable vitiligo diagnosis Age between 15 to 50 years Stable lesions Patients who 6 months past from the last lesion

Exclusion criteria

Exclusion criteria: Lactating and pregnant women Vitiligo, which affects more than 50% of the body surface area History of reconstructive disorders and hypertrophic scars

Design outcomes

Primary

Measure	Time frame
Pigmentation. Timepoint: The first week, three months later, every 2 months up to 12 months. Method of measurement: Medical Imaging.;Possible complications. Timepoint: The first week, three months later, every 2 months up to 12 months. Method of measurement: Medical Imaging.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEiraj Ghorbani

Kermanshah University of Medical Sciences

dr.ghorbanii_1812 @yahoo.com+98 83 3427 4618

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026